Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Anti-inflammatory therapeutic is a drug that used in acute and chronic pain as well as inflammation (redness, swelling and pain). Anti-inflammatory drugs blocks certain substances in the body which cause inflammation. They are used in treatment of many different indications such as treat migraines, headache, rheumatic arthritis, sprains and menstrual pain. Additionally, some anti-inflammatory agents such as celecoxib and ibuprofen are being studied for the prevention and treatment of cancer. Furthermore, they can provide faster relief as compared to another drugs. They are also capable of lowering the levels of prostaglandin and the chemical responsible for inflammations, thereby reducing pain and swelling. Anti-inflammatory drugs usually target the anti-inflammatory mediators or enzymes.
The anti-inflammatory therapeutics market is anticipated to grow at CAGR of 5.43% during the forecast period of 2021 to 2027. The anti-inflammatory agents used in combination of other drugs. Inflammation is the most prevalent treatment symptoms among many immune and respiratory diseases. The major factors such as increase in prevalence of autoimmune & respiratory conditions is propelling growth of anti-inflammatory therapeutics market. Rise in awareness of anti-inflammatory therapeutics is boosting growth of anti-inflammatory therapeutics market. However, side effects of anti-inflammatory drugs is hampering the growth of anti-inflammatory therapeutics market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the anti-inflammatory therapeutics market. In addition, complete analysis of changes on anti-inflammatory therapeutics organizations expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. Owing to inflammation caused by COVID-19 virus which causes severe pneumonia the anti-inflammatory therapeutics market is witnessing rapid growth. The cytokine rage is chief cause of death in COVID-19 affected patients. Some of the consequences of severe inflammation and cytokine storm comprised of the acute respiratory distress syndrome, acute lung injury and multiple organ dysfunction syndrome which leads to research and development of anti-inflammatory drugs for treatment of the inflammation caused by the COVID-19. Thus, such factors have impacted positively on the growth of anti-inflammatory therapeutics market during the COVID-19 pandemics.
The anti-inflammatory therapeutics market is segmented into drug class, indication, end user and geography.
The anti-inflammatory therapeutics market is comprised of drug class such as anti-inflammatory biologics, non-steroidal anti-inflammatory drugs, corticosteroids, immune-selective anti-inflammatory derivative and other. In which anti-inflammatory biologics is expected to dominate the market in 2020. The rising population affected by chronic diseases is propelling growth of anti-inflammatory therapeutics market. Unavailability of effective treatments is boosting the growth of anti-inflammatory therapeutics market. The growing awareness of biologics is driving growth of anti-inflammatory therapeutics market.
The anti-inflammatory therapeutics market is comprised of indications such as arthritis, chronic obstructive pulmonary diseases, multiple sclerosis, inflammatory bowel diseases, asthma, tendonitis and other. In which arthritis is estimated to dominate the market in 2020. The increase in prevalence of osteoarthritis and rheumatoid arthritis is boosting the growth of anti-inflammatory therapeutics market. Rising use of topical drugs for treating arthritis pain is also refuelling growth of anti-inflammatory therapeutics market.
The anti-inflammatory therapeutics market is comprised of end user such as hospital pharmacies, online pharmacies and retail pharmacies. In which hospital pharmacies is likely to dominate the market in 2020. The rising outflow of patients is propelling the growth of the anti-inflammatory therapeutics market. The rising geriatric populations is also boosting growth of anti-inflammatory therapeutics market. The rising cases of respiratory diseases is also refuelling growth of anti-inflammatory therapeutics market.
The anti-inflammatory therapeutics market is studied for key countries of regions such as North America, Europe, Asia Pacific and Rest of the World. The North America is anticipated to dominate the market in 2020. The high expenditure on R&D is propelling growth of the anti-inflammatory therapeutics market. Presence of major key players is boosting the growth of anti-inflammatory therapeutics market. Rise in usage of OTC non-steroidal anti-inflammatory drugs is also driving the growth of anti-inflammatory therapeutics market.
The major key players operating in the market are Amgen Inc, Astrazeneca Plc., Eli Lily And Company., Hoffmann-La Roche Ag, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Ag and Pfizer Inc among others.
Jun 2020: FDA approved Novartis Ilaris which contains canakinumab for new indication to treat adult-onset still’s disease (AOSD).
March 2020: GSK’s consumer healthcare launched the biggest innovation in the U.S. as Over the counter oral pain relief category under the brand name of Advil dual action which comprised of the acetaminophen and ibuprofen.
The study comprised of the anti-inflammatory therapeutics market. In which study analysed the various segment of the market such as drug class, indication, end user and geography. The study also comprised of dominating segment of the market. The drug class segments is dominated by anti-inflammatory biologics. Likewise, indication segment is dominated by arthritis, end user segment is dominated by hospital pharmacies and geographical segment is dominated by the North America. The study also covers the impact of COVID-19 on the anti-inflammatory therapeutics market and concludes that the COVID-19 has almost affected every market is healthcare industries positively or negatively. Owing to inflammation caused by COVID-19 virus which causes severe pneumonia the anti-inflammatory therapeutics market is witnessing rapid growth. The cytokine rage is chief cause of death in COVID-19 affected patients. Some of the consequences of severe inflammation and cytokine storm comprised of the acute respiratory distress syndrome, acute lung injury and multiple organ dysfunction syndrome which leads to research and development of anti-inflammatory drugs for treatment of the inflammation caused by the COVID-19. Thus, such factors have impacted positively on the growth of anti-inflammatory therapeutics market during the COVID-19 pandemics. The study also imparts the major key players operating in the market.
Why to buy this report
